Metastasis
Venous Thrombosis I: Introduction
Tumor Immunotherapy
The Tumor Microenvironment
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 18, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
1GefäßCentrum, CCB - Cardioangiologisches Centrum Bethanien, Frankfurt am Main, Germany.
Direct FXa inhibitors offer a safer, more effective anticoagulation therapy for cancer-associated thrombosis (CAT) than traditional Low Molecular Weight Heparin (LMWH). Oral therapies require caution, especially with certain tumors, but dose reduction may be suitable for select patients.
Area of Science: